Because of this, some researchers have proposed that ITGB6 can be employed as a new serum biomarker for the detection and evaluation of colon cancer, as well as a marker for tumor monitoring, recurrence, and therapeutic response (Bengs et al., 2019). Here, ITGB6 is linked to malignant colon neoplasm.